title: Alanyl-glutamine promotes intestinal epithelial cell homeostasis in vitro and in a murine model of weanling undernutrition.
abstract: Alanyl-glutamine (Ala-Gln) has recently been shown to enhance catch-up growth and gut integrity in undernourished children from Northeast Brazil. We hypothesized that the intestinal epithelial effects of Ala-Gln in malnourished weanling mice and mouse small intestinal epithelial (MSIE) cells would include modulation of barrier function, proliferation, and apoptosis. Dams of 10-day-old suckling C57BL/6 pups were randomized to a standard diet or an isocaloric Northeast Brazil "regional basic diet," moderately deficient in protein, fat, and minerals. Upon weaning to their dam's diet on day of life 21, pups were randomized to Ala-Gln solution or water. At 6 wk of age, mice were killed, and jejunal tissue was collected for morphology, immunohistochemistry, and Ussing chamber analysis of transmucosal resistance and permeability. Proliferation of MSIE cells in the presence or absence of Ala-Gln was measured by MTS and bromodeoxyuridine assays. MSIE apoptosis was assessed by annexin and 7-amino-actinomycin D staining. Pups of regional basic diet-fed dams exhibited failure to thrive. Jejunal specimens from undernourished weanlings showed decreased villous height and crypt depth, decreased transmucosal resistance, increased permeability to FITC-dextran, increased claudin-3 expression, and decreased epithelial proliferation and increased epithelial apoptosis (as measured by bromodeoxyuridine and cleaved caspase-3 staining, respectively). Undernourished weanlings supplemented with Ala-Gln showed improvements in weight velocity, villous height, crypt depth, transmucosal resistance, and epithelial proliferation/apoptosis compared with unsupplemented controls. Similarly, Ala-Gln increased proliferation and reduced apoptosis in MSIE cells. In summary, Ala-Gln promotes intestinal epithelial homeostasis in a mouse model of malnutrition-associated enteropathy, mimicking key features of the human disease.
authors.affiliation: Cincinnati Children's Hospital Medical Center, OH 45229-3039, USA.
authors.forename: Priscilla M
authors.initials: PM
authors.lastname: Ueno
authors.forename: Reinaldo B
authors.initials: RB
authors.lastname: Oriá
authors.forename: Elizabeth A
authors.initials: EA
authors.lastname: Maier
authors.forename: Marjorie
authors.initials: M
authors.lastname: Guedes
authors.forename: Orleancio G
authors.initials: OG
authors.lastname: de Azevedo
authors.forename: David
authors.initials: D
authors.lastname: Wu
authors.forename: Tara
authors.initials: T
authors.lastname: Willson
authors.forename: Simon P
authors.initials: SP
authors.lastname: Hogan
authors.forename: Aldo A M
authors.initials: AA
authors.lastname: Lima
authors.forename: Richard L
authors.initials: RL
authors.lastname: Guerrant
authors.forename: D Brent
authors.initials: DB
authors.lastname: Polk
authors.forename: Lee A
authors.initials: LA
authors.lastname: Denson
authors.forename: Sean R
authors.initials: SR
authors.lastname: Moore
mesh_terms: D000818:Animals; D017209:Apoptosis / Q000187:drug effects; D049109:Cell Proliferation / Q000187:drug effects; D004151:Dipeptides / Q000494:pharmacology*; D004847:Epithelial Cells / Q000187:drug effects / Q000502:physiology; D006706:Homeostasis / Q000187:drug effects; D007413:Intestinal Mucosa / Q000187:drug effects / Q000502:physiology; D007421:Intestine, Small / Q000166:cytology / Q000187:drug effects*; D044342:Malnutrition / Q000378:metabolism*; D051379:Mice; D008810:Mice, Inbred C57BL; D014886:Weaning
chemical_list: D004151:Dipeptides; C054122:alanylglutamine